首页 > 最新文献

Turkish Journal of Physical Medicine and Rehabilitation最新文献

英文 中文
Effect of platelet-rich plasma injections versus placebo on pain and quality of life in patients with hip osteoarthritis: A double-blind, randomized clinical trial. 注射富血小板血浆与安慰剂对髋关节骨关节炎患者疼痛和生活质量的影响:双盲随机临床试验。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-17 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.13855
Mahir Topaloglu, Ekin İlke Şen, Deniz Sarıkaya, Demirhan Dıraçoğlu

Objectives: This study aims to compare the efficacy of intra-articular platelet-rich plasma (PRP) injections over a saline placebo in terms of reduction of pain and impact on quality of life among patients with hip osteoarthritis.

Patients and methods: A total of 60 patients (29 males, 31 females, mean age: 57.9±7.3 years; range, 47 to 69 years) with known hip osteoarthritis of Kellgren-Lawrance (KL) Grades 2/3 were randomized into placebo (n=30) and PRP groups (n=30) between June 2014 and June 2015. Both groups received intra-articular injections into the hip joint under ultrasound guidance for three consecutive weeks. The patients were followed for six months, and pain reduction was assessed using the Visual Analog Scale (VAS), Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire, and Short Form Health Survey-36 (SF-36).

Results: Intra-articular PRP treatment showed no advantage over a saline placebo in terms of VAS scores during activity. Both groups showed a significant improvement in VAS activity scores at one and six months. The placebo group showed improvements in VAS resting scores, whereas the PRP group did not. Both groups showed no improvement in WOMAC-total scores. Both groups showed no significant improvement across most SF-36 domains with the exception of improved physical role functioning at one month and general health at one and six months in the placebo group.

Conclusion: Intra-articular injections of PRP show no significant difference compared to a saline placebo over a period of six months on pain, function, and quality of life scores in patients with hip osteoarthritis.

研究目的本研究旨在比较关节内注射富血小板血浆(PRP)与生理盐水安慰剂在减轻髋关节骨关节炎患者疼痛和提高生活质量方面的疗效:2014年6月至2015年6月期间,共有60名已知患有Kellgren-Lawrance(KL)2/3级髋关节骨关节炎的患者(29名男性,31名女性,平均年龄:57.9±7.3岁;范围:47至69岁)被随机分为安慰剂组(30人)和PRP组(30人)。两组患者均在超声引导下接受连续三周的髋关节内注射。对患者进行了为期6个月的随访,并使用视觉模拟量表(VAS)、西安大略和麦克马斯特大学关节炎指数(WOMAC)问卷以及简表健康调查-36(SF-36)对疼痛减轻情况进行了评估:结果:就活动时的 VAS 评分而言,关节内 PRP 治疗与生理盐水安慰剂相比没有优势。两组患者在 1 个月和 6 个月后的 VAS 活动评分均有明显改善。安慰剂组的 VAS 休息评分有所改善,而 PRP 组则没有。两组的 WOMAC 总分均无改善。两组在大多数 SF-36 领域均无明显改善,只有安慰剂组在一个月时身体角色功能有所改善,在一个月和六个月时总体健康状况有所改善:结论:与生理盐水安慰剂相比,PRP 关节内注射在六个月内对髋关节骨关节炎患者的疼痛、功能和生活质量评分没有明显差异。
{"title":"Effect of platelet-rich plasma injections versus placebo on pain and quality of life in patients with hip osteoarthritis: A double-blind, randomized clinical trial.","authors":"Mahir Topaloglu, Ekin İlke Şen, Deniz Sarıkaya, Demirhan Dıraçoğlu","doi":"10.5606/tftrd.2024.13855","DOIUrl":"10.5606/tftrd.2024.13855","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to compare the efficacy of intra-articular platelet-rich plasma (PRP) injections over a saline placebo in terms of reduction of pain and impact on quality of life among patients with hip osteoarthritis.</p><p><strong>Patients and methods: </strong>A total of 60 patients (29 males, 31 females, mean age: 57.9±7.3 years; range, 47 to 69 years) with known hip osteoarthritis of Kellgren-Lawrance (KL) Grades 2/3 were randomized into placebo (n=30) and PRP groups (n=30) between June 2014 and June 2015. Both groups received intra-articular injections into the hip joint under ultrasound guidance for three consecutive weeks. The patients were followed for six months, and pain reduction was assessed using the Visual Analog Scale (VAS), Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire, and Short Form Health Survey-36 (SF-36).</p><p><strong>Results: </strong>Intra-articular PRP treatment showed no advantage over a saline placebo in terms of VAS scores during activity. Both groups showed a significant improvement in VAS activity scores at one and six months. The placebo group showed improvements in VAS resting scores, whereas the PRP group did not. Both groups showed no improvement in WOMAC-total scores. Both groups showed no significant improvement across most SF-36 domains with the exception of improved physical role functioning at one month and general health at one and six months in the placebo group.</p><p><strong>Conclusion: </strong>Intra-articular injections of PRP show no significant difference compared to a saline placebo over a period of six months on pain, function, and quality of life scores in patients with hip osteoarthritis.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209330/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local ozone injection compared to local glucocorticoid injection in carpal tunnel syndrome: A randomized controlled trial. 局部臭氧注射与局部糖皮质激素注射治疗腕管综合征的比较:随机对照试验
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-17 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.12590
Farnaz Hesam, Amid-Aldin Khatibi, Mohamadreza Vafaeenasab, Behnaz Tirandazi, Fereshteh Sharifi Dorcheh

Objectives: This study aimed to compare the effectiveness of local ozone (O3) injection versus corticosteroid injection in the treatment of mild to moderate carpal tunnel syndrome (CTS).

Patients and methods: This double-blind randomized controlled trial was performed on 42 patients (9 males, 33 females; mean age: 46.7±2.1 years; range, 18 to 70 years) with mild to moderate CTS between May 2021 and June 2021. The corticosteroid group (n=21) was injected with 40 mg triamcinolone, and in the O3 group B (n=21), 4 mL of a 10 mcg/mL oxygen (O2)-O3 mixture was injected. Symptom severity and functional impairments were assessed using a Visual Analog Scale and Boston Carpal Tunnel Questionnaire. Electrodiagnostic and ultrasonographic parameters were obtained at baseline and eight weeks after the procedure.

Results: The O2-O3 solution improved pain and Boston Carpal Tunnel Questionnaire score after eight weeks (p<0.001); however, the change was nonsignificant compared to the corticosteroid group (p>0.05). Sensory nerve and compound muscle action potential latencies were not significantly changed eight weeks after O2-O3 injection (p>0.05), while both were significantly decreased in the steroid injection group (p<0.001). Volar bulging and median nerve cross-section surface area were not improved after O2-O3 injection, while the improvement was significant in the corticosteroid arm (p=0.02).

Conclusion: Symptoms in patients with mild to moderate CTS may be alleviated by local O2-O3 injection; however, electrodiagnostic and ultrasonographic indices may be unchanged. Corticosteroid local injection may alleviate patient symptoms along with electrodiagnostic and ultrasonographic parameters.

研究目的本研究旨在比较局部臭氧(O3)注射与皮质类固醇注射治疗轻中度腕管综合征(CTS)的效果:这项双盲随机对照试验在2021年5月至2021年6月期间对42名轻中度CTS患者(9名男性,33名女性;平均年龄:46.7±2.1岁;18至70岁)进行了治疗。皮质类固醇组(21 人)注射 40 毫克曲安奈德,O3 B 组(21 人)注射 4 毫升 10 微克/毫升氧气(O2)-O3 混合物。采用视觉模拟量表和波士顿腕管问卷对症状严重程度和功能障碍进行评估。电诊断和超声波参数分别在基线和术后八周获得:结果:八周后,O2-O3 溶液改善了疼痛和波士顿腕管问卷评分(P0.05)。注射 O2-O3 八周后,感觉神经和复合肌动作电位潜伏期无明显变化(p>0.05),而类固醇注射组的感觉神经和复合肌动作电位潜伏期均明显下降(p2-O3 注射组,皮质类固醇注射组改善明显(p=0.02):结论:局部注射 O2-O3 可减轻轻度至中度 CTS 患者的症状,但电诊断和超声波检查指标可能不会改变。皮质类固醇局部注射可减轻患者症状,同时缓解电诊断和超声波检查指标。
{"title":"Local ozone injection compared to local glucocorticoid injection in carpal tunnel syndrome: A randomized controlled trial.","authors":"Farnaz Hesam, Amid-Aldin Khatibi, Mohamadreza Vafaeenasab, Behnaz Tirandazi, Fereshteh Sharifi Dorcheh","doi":"10.5606/tftrd.2024.12590","DOIUrl":"10.5606/tftrd.2024.12590","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to compare the effectiveness of local ozone (O<sub>3</sub>) injection versus corticosteroid injection in the treatment of mild to moderate carpal tunnel syndrome (CTS).</p><p><strong>Patients and methods: </strong>This double-blind randomized controlled trial was performed on 42 patients (9 males, 33 females; mean age: 46.7±2.1 years; range, 18 to 70 years) with mild to moderate CTS between May 2021 and June 2021. The corticosteroid group (n=21) was injected with 40 mg triamcinolone, and in the O<sub>3</sub> group B (n=21), 4 mL of a 10 mcg/mL oxygen (O<sub>2</sub>)-O<sub>3</sub> mixture was injected. Symptom severity and functional impairments were assessed using a Visual Analog Scale and Boston Carpal Tunnel Questionnaire. Electrodiagnostic and ultrasonographic parameters were obtained at baseline and eight weeks after the procedure.</p><p><strong>Results: </strong>The O<sub>2</sub>-O<sub>3</sub> solution improved pain and Boston Carpal Tunnel Questionnaire score after eight weeks (p<0.001); however, the change was nonsignificant compared to the corticosteroid group (p>0.05). Sensory nerve and compound muscle action potential latencies were not significantly changed eight weeks after O<sub>2</sub>-O<sub>3</sub> injection (p>0.05), while both were significantly decreased in the steroid injection group (p<0.001). Volar bulging and median nerve cross-section surface area were not improved after O<sub>2</sub>-O<sub>3</sub> injection, while the improvement was significant in the corticosteroid arm (p=0.02).</p><p><strong>Conclusion: </strong>Symptoms in patients with mild to moderate CTS may be alleviated by local O<sub>2</sub>-O<sub>3</sub> injection; however, electrodiagnostic and ultrasonographic indices may be unchanged. Corticosteroid local injection may alleviate patient symptoms along with electrodiagnostic and ultrasonographic parameters.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209334/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive analysis of publication of physical medicine and rehabilitation theses in Türkiye between years 2010 and 2020: Academic productivity and related factors. 2010 年至 2020 年土耳其物理医学与康复论文发表情况综合分析:学术生产力及相关因素。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-17 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.12995
Bilge Yılmaz, Pelin Mutlu Arı, Hilal Büşra Ayçiçek, Gökhan Yardımcı

Objectives: This study aimed to investigate the publication rates of physical medicine and rehabilitation specialty training theses, which are required to complete a residency in Türkiye, and determine the factors that affect publication.

Materials and methods: Residency theses involved in this descriptive study were detected from the database of Higher Education Council Thesis Center (tez.yok.gov.tr) between January 2010 and December 2020. Publication of theses and date of publication were investigated by the writer's and supervisor's names on PubMed and Google Scholar.

Results: Three hundred eighty-eight of 1,130 theses were turned into publications. Two hundred seventy-seven (24.5%) were published in SCI (Science Citation Index)/SCI Expanded indexed journals. The publication rates of residents were 47.1% in private universities, 34.2% in public universities, and 32.3% in training and research hospitals. The trainees who published their theses were more likely to become associate and assistant professors.

Conclusion: Although approximately one-third of the theses defended were published, this rate is insufficient for sharing the knowledge. Considering that publishing their theses affected the residents' current academic careers positively, supervisors should provide the residents supportive facilitation to give the knowledge in research and publish their theses.

研究目的本研究旨在调查在土耳其完成住院医师培训所需的物理医学与康复专业培训论文的发表率,并确定影响发表的因素:本描述性研究涉及的住院医师培训论文均来自高等教育委员会论文中心数据库(tez.yok.gov.tr),时间跨度为 2010 年 1 月至 2020 年 12 月。在PubMed和Google Scholar上通过作者和导师的姓名调查论文的发表情况和发表日期:在 1130 篇论文中,有 388 篇被发表。其中 277 篇(24.5%)在 SCI(科学引文索引)/SCI Expanded 期刊上发表。住院医师的论文发表率分别为:私立大学 47.1%、公立大学 34.2%、培训与研究医院 32.3%。发表论文的学员更有可能成为副教授和助理教授:尽管约有三分之一的答辩论文得以发表,但这一比例还不足以实现知识共享。考虑到发表论文对住院医师目前的学术生涯产生了积极影响,导师应为住院医师提供支持性便利,使其在研究和发表论文方面获得知识。
{"title":"Comprehensive analysis of publication of physical medicine and rehabilitation theses in Türkiye between years 2010 and 2020: Academic productivity and related factors.","authors":"Bilge Yılmaz, Pelin Mutlu Arı, Hilal Büşra Ayçiçek, Gökhan Yardımcı","doi":"10.5606/tftrd.2024.12995","DOIUrl":"10.5606/tftrd.2024.12995","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate the publication rates of physical medicine and rehabilitation specialty training theses, which are required to complete a residency in Türkiye, and determine the factors that affect publication.</p><p><strong>Materials and methods: </strong>Residency theses involved in this descriptive study were detected from the database of Higher Education Council Thesis Center (tez.yok.gov.tr) between January 2010 and December 2020. Publication of theses and date of publication were investigated by the writer's and supervisor's names on PubMed and Google Scholar.</p><p><strong>Results: </strong>Three hundred eighty-eight of 1,130 theses were turned into publications. Two hundred seventy-seven (24.5%) were published in SCI (Science Citation Index)/SCI Expanded indexed journals. The publication rates of residents were 47.1% in private universities, 34.2% in public universities, and 32.3% in training and research hospitals. The trainees who published their theses were more likely to become associate and assistant professors.</p><p><strong>Conclusion: </strong>Although approximately one-third of the theses defended were published, this rate is insufficient for sharing the knowledge. Considering that publishing their theses affected the residents' current academic careers positively, supervisors should provide the residents supportive facilitation to give the knowledge in research and publish their theses.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which aerobic exercise is more effective in Parkinson's patients? Cycle ergometer versus body weight-supported treadmill. 哪种有氧运动对帕金森病患者更有效?自行车测力计与体重支撑跑步机。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-17 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.11991
Merve Yalçın Tavşan, Gökay Taylan, Maryam Zare, Hande Özdemir, Filiz Tuna, Necdet Süt, Sibel Güler, Muhammet Gürdoğan, Derya Demirbağ Kabayel

Objectives: The study aimed to evaluate the effects of aerobic exercise applied with bodyweight-supported treadmill (BWSTT) or cycle ergometer (CE) in Parkinson's patients.

Patients and methods: In the prospective single-blind study, 38 Parkinson's patients with Hoehn-Yahr Stage 1-3 were randomized into the CE and BWSTT groups between May 2019 and March 2020. Evaluations before and after six weeks of treatment included a six-min walking test with a software device as the primary outcome and functional balance tests (Tinetti balance and gait test, one-leg stance balance test) as secondary outcomes. Both groups received 40 min of aerobic exercise three days per week with conventional rehabilitation and various methods. CE and BWSTT groups were created. The aerobic exercise program was designed based on treatment recommendations for Parkinson's patients of the American College of Sports Medicine (CE test, with the Karvonen formula, 40-60% reserve). Posttreatment and pretreatment evaluations were compared within and between groups.

Results: The six-week aerobic exercise program was completed by 16 participants (9 males, 7 females; mean age: 65.9±8.1; range, 47 to 78 years) in the CE group and 15 participants (9 males, 6 females; mean age: 62.5±7.5; range, 49 to 79 years) in the BWSTT group. The demographic characteristics of the patients were similar. Primary and secondary outcomes were significantly different after treatment than before treatment in both groups. There were no significant differences between the groups in outcomes.

Conclusion: The results showed that both methods are effective and not superior to each other. Aerobic exercise programs led by experienced clinicians can benefit patients.

研究目的研究旨在评估帕金森病患者使用体重支撑跑步机(BWSTT)或自行车测力计(CE)进行有氧运动的效果:在这项前瞻性单盲研究中,38名Hoehn-Yahr 1-3期帕金森患者在2019年5月至2020年3月期间被随机分为CE组和BWSTT组。治疗前后六周的评估包括作为主要结果的软件设备六分钟步行测试和作为次要结果的功能平衡测试(Tinetti 平衡和步态测试、单腿站立平衡测试)。两组患者均接受每周三天、每次 40 分钟的有氧运动,并采用传统康复训练和各种方法。分为 CE 组和 BWSTT 组。有氧运动项目是根据美国运动医学学会对帕金森病人的治疗建议设计的(CE 测试,采用卡沃宁公式,40-60% 储备)。在组内和组间比较了治疗后和治疗前的评估结果:CE组和BWSTT组分别有16人(9男7女;平均年龄:65.9±8.1;年龄范围:47至78岁)和15人(9男6女;平均年龄:62.5±7.5;年龄范围:49至79岁)完成了为期六周的有氧运动计划。患者的人口统计学特征相似。两组患者治疗后的主要和次要结果与治疗前相比均有显著差异。两组间的结果无明显差异:结果表明,两种方法都有效,但并无优劣之分。由经验丰富的临床医生领导的有氧运动计划可使患者受益。
{"title":"Which aerobic exercise is more effective in Parkinson's patients? Cycle ergometer versus body weight-supported treadmill.","authors":"Merve Yalçın Tavşan, Gökay Taylan, Maryam Zare, Hande Özdemir, Filiz Tuna, Necdet Süt, Sibel Güler, Muhammet Gürdoğan, Derya Demirbağ Kabayel","doi":"10.5606/tftrd.2024.11991","DOIUrl":"10.5606/tftrd.2024.11991","url":null,"abstract":"<p><strong>Objectives: </strong>The study aimed to evaluate the effects of aerobic exercise applied with bodyweight-supported treadmill (BWSTT) or cycle ergometer (CE) in Parkinson's patients.</p><p><strong>Patients and methods: </strong>In the prospective single-blind study, 38 Parkinson's patients with Hoehn-Yahr Stage 1-3 were randomized into the CE and BWSTT groups between May 2019 and March 2020. Evaluations before and after six weeks of treatment included a six-min walking test with a software device as the primary outcome and functional balance tests (Tinetti balance and gait test, one-leg stance balance test) as secondary outcomes. Both groups received 40 min of aerobic exercise three days per week with conventional rehabilitation and various methods. CE and BWSTT groups were created. The aerobic exercise program was designed based on treatment recommendations for Parkinson's patients of the American College of Sports Medicine (CE test, with the Karvonen formula, 40-60% reserve). Posttreatment and pretreatment evaluations were compared within and between groups.</p><p><strong>Results: </strong>The six-week aerobic exercise program was completed by 16 participants (9 males, 7 females; mean age: 65.9±8.1; range, 47 to 78 years) in the CE group and 15 participants (9 males, 6 females; mean age: 62.5±7.5; range, 49 to 79 years) in the BWSTT group. The demographic characteristics of the patients were similar. Primary and secondary outcomes were significantly different after treatment than before treatment in both groups. There were no significant differences between the groups in outcomes.</p><p><strong>Conclusion: </strong>The results showed that both methods are effective and not superior to each other. Aerobic exercise programs led by experienced clinicians can benefit patients.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter to the Editor: Yoga and naturopathy for COVID 2019. 回应致编辑的信:COVID 2019 的瑜伽和自然疗法。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-16 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.96257
Refiye Önal, Nilüfer Kutay Ordu Gökkaya, Serap Korkmaz, Burkay Utku, Evren Yaşar
{"title":"Response to Letter to the Editor: Yoga and naturopathy for COVID 2019.","authors":"Refiye Önal, Nilüfer Kutay Ordu Gökkaya, Serap Korkmaz, Burkay Utku, Evren Yaşar","doi":"10.5606/tftrd.2024.96257","DOIUrl":"10.5606/tftrd.2024.96257","url":null,"abstract":"","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current neuroprotective agents in stroke. 目前治疗中风的神经保护剂。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-16 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.15287
Tuğra Yanık, Burcu Yanık

What is expected from neuroprotection is to inhibit neuronal death and halt or decelerate the neuronal loss to lower the mortality rates, decrease disability, and improve the quality of life following an acute ischemic stroke. Several agents were described as neuroprotective up to date; however, there is still debate which to use in the neurorehabilitation of stroke patients, in terms of both efficacy and also safety. In this review, we discuss the agents, citicoline, cerebrolysin and MLC901 (NeuroAiD II), the three agents which have started to be used frequently in neurorehabilitation clinics recently in the light of the current literature.

神经保护的预期目标是抑制神经元死亡,阻止或减缓神经元损失,从而降低急性缺血性中风后的死亡率,减少残疾,提高生活质量。迄今为止,已有多种药物被描述为具有神经保护作用;然而,在脑卒中患者的神经康复中使用哪种药物在疗效和安全性方面仍存在争议。在这篇综述中,我们将讨论柠檬胆碱、脑溶酶和 MLC901(NeuroAiD II)这三种药物,根据目前的文献资料,这三种药物最近开始在神经康复诊所频繁使用。
{"title":"Current neuroprotective agents in stroke.","authors":"Tuğra Yanık, Burcu Yanık","doi":"10.5606/tftrd.2024.15287","DOIUrl":"10.5606/tftrd.2024.15287","url":null,"abstract":"<p><p>What is expected from neuroprotection is to inhibit neuronal death and halt or decelerate the neuronal loss to lower the mortality rates, decrease disability, and improve the quality of life following an acute ischemic stroke. Several agents were described as neuroprotective up to date; however, there is still debate which to use in the neurorehabilitation of stroke patients, in terms of both efficacy and also safety. In this review, we discuss the agents, citicoline, cerebrolysin and MLC901 (NeuroAiD II), the three agents which have started to be used frequently in neurorehabilitation clinics recently in the light of the current literature.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to complete decongestive therapy in patients with postmastectomy lymphedema and related factors. 乳房切除术后淋巴水肿患者坚持完全去充血疗法及相关因素。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-16 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.12178
Habibe Kandasoglu, Sibel Unsal Delialioglu

Objectives: The study aimed to determine the rates of adherence to phase 2 components of complex decongestive therapy (CDT) and related factors among patients with postmastectomy lymphedema.

Patients and methods: This cross-sectional study included 90 female patients (mean age: 54.4±8.0 years; range, 24 to 65 years) with unilateral postmastectomy lymphedema who completed chemotherapy or radiotherapy and had previously undergone CDT phase 1 at our clinic or elsewhere between May 2018 and May 2019. Patients were included in the study at their usual visit to the lymphedema polyclinic. After physical examination, study questionnaires that involved patients' demographic and clinic data and Lymphedema Quality of Life scores were recorded. Patients who applied CDT phase 2 methods four days a week or more frequently were considered adherent, while those who applied these methods less frequently or who never applied these methods were considered nonadherent. The body mass index (BMI) scores were classified based on the criteria of the World Health Organization.

Results: Lymphedema stages of the patients were Stage I in 33.3% (n=30), Stage II in 60% (n=54), and Stage III in 6.7% (n=6). The rates of adherence were 74.4% (n=67) for skin care, 46.6% (n=42) for compression garment use, 42.2% (n=38) for self-massage, 42.2% (n=38) for exercise, and 18.8% (n=17) for multilayer bandaging. The rate of adherence to the multilayer bandaging method was found to be significantly higher in the obese group (BMI >30) than in the other BMI groups.

Conclusion: Patient adherence to CDT phase 2 was not sufficient except for the skin care component. There was a significant relationship between BMI and adherence to multilayer bandaging.

研究目的该研究旨在确定乳房切除术后淋巴水肿患者对复杂去充血疗法(CDT)第二阶段组成部分的坚持率及相关因素:这项横断面研究纳入了90名单侧切除术后淋巴水肿的女性患者(平均年龄:54.4±8.0岁;范围:24至65岁),这些患者在2018年5月至2019年5月期间完成了化疗或放疗,并曾在本诊所或其他地方接受过CDT第一阶段治疗。患者在通常前往淋巴水肿综合门诊就诊时被纳入研究。体格检查后,记录涉及患者人口统计学和临床数据以及淋巴水肿生活质量评分的研究问卷。每周使用 CDT 第二阶段方法四天或更频繁的患者被视为坚持使用,而使用频率较低或从未使用过这些方法的患者被视为未坚持使用。体重指数(BMI)评分根据世界卫生组织的标准进行分类:结果:患者的淋巴水肿分期为 I 期的占 33.3%(30 人),II 期的占 60%(54 人),III 期的占 6.7%(6 人)。皮肤护理的坚持率为 74.4%(n=67),使用压力衣的坚持率为 46.6%(n=42),自我按摩的坚持率为 42.2%(n=38),运动的坚持率为 42.2%(n=38),多层包扎的坚持率为 18.8%(n=17)。研究发现,肥胖组(体重指数大于 30)对多层包扎法的坚持率明显高于其他体重指数组:结论:除皮肤护理部分外,患者对 CDT 第二阶段的依从性不足。结论:除皮肤护理部分外,患者对 CDT 第 2 阶段的依从性不足,体重指数与多层包扎法的依从性之间存在明显关系。
{"title":"Adherence to complete decongestive therapy in patients with postmastectomy lymphedema and related factors.","authors":"Habibe Kandasoglu, Sibel Unsal Delialioglu","doi":"10.5606/tftrd.2024.12178","DOIUrl":"10.5606/tftrd.2024.12178","url":null,"abstract":"<p><strong>Objectives: </strong>The study aimed to determine the rates of adherence to phase 2 components of complex decongestive therapy (CDT) and related factors among patients with postmastectomy lymphedema.</p><p><strong>Patients and methods: </strong>This cross-sectional study included 90 female patients (mean age: 54.4±8.0 years; range, 24 to 65 years) with unilateral postmastectomy lymphedema who completed chemotherapy or radiotherapy and had previously undergone CDT phase 1 at our clinic or elsewhere between May 2018 and May 2019. Patients were included in the study at their usual visit to the lymphedema polyclinic. After physical examination, study questionnaires that involved patients' demographic and clinic data and Lymphedema Quality of Life scores were recorded. Patients who applied CDT phase 2 methods four days a week or more frequently were considered adherent, while those who applied these methods less frequently or who never applied these methods were considered nonadherent. The body mass index (BMI) scores were classified based on the criteria of the World Health Organization.</p><p><strong>Results: </strong>Lymphedema stages of the patients were Stage I in 33.3% (n=30), Stage II in 60% (n=54), and Stage III in 6.7% (n=6). The rates of adherence were 74.4% (n=67) for skin care, 46.6% (n=42) for compression garment use, 42.2% (n=38) for self-massage, 42.2% (n=38) for exercise, and 18.8% (n=17) for multilayer bandaging. The rate of adherence to the multilayer bandaging method was found to be significantly higher in the obese group (BMI >30) than in the other BMI groups.</p><p><strong>Conclusion: </strong>Patient adherence to CDT phase 2 was not sufficient except for the skin care component. There was a significant relationship between BMI and adherence to multilayer bandaging.</p>","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter to the Editor: The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study. 回应致编辑的信:泰卡疗法对 2 型糖尿病患者周围神经病变的神经紊乱和下肢神经传导速度的影响:为期六周的随访研究。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-16 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.96258
Maryam Niajalili, Mohamad Mohsen Roostayi, Aliyeh Daryabor, Sedigheh Sadat Naimi, Mitra Javan Amoli
{"title":"Response to Letter to the Editor: The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study.","authors":"Maryam Niajalili, Mohamad Mohsen Roostayi, Aliyeh Daryabor, Sedigheh Sadat Naimi, Mitra Javan Amoli","doi":"10.5606/tftrd.2024.96258","DOIUrl":"10.5606/tftrd.2024.96258","url":null,"abstract":"","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209329/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study. 泰卡疗法对 2 型糖尿病患者周围神经病变的神经紊乱和下肢神经传导速度的影响:为期六周的随访研究
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-16 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.14394
Adarsh Sharma, Jeyanthi S
{"title":"The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study.","authors":"Adarsh Sharma, Jeyanthi S","doi":"10.5606/tftrd.2024.14394","DOIUrl":"10.5606/tftrd.2024.14394","url":null,"abstract":"","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Yoga and naturopathy for COVID 2019. COVID 2019 的瑜伽和自然疗法。
IF 1.1 4区 医学 Q3 REHABILITATION Pub Date : 2024-05-16 eCollection Date: 2024-06-01 DOI: 10.5606/tftrd.2024.14831
M Alkousar Taz, Venugopal Vijayakumar, Maheshkumar Kuppusamy
{"title":"Yoga and naturopathy for COVID 2019.","authors":"M Alkousar Taz, Venugopal Vijayakumar, Maheshkumar Kuppusamy","doi":"10.5606/tftrd.2024.14831","DOIUrl":"10.5606/tftrd.2024.14831","url":null,"abstract":"","PeriodicalId":56043,"journal":{"name":"Turkish Journal of Physical Medicine and Rehabilitation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkish Journal of Physical Medicine and Rehabilitation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1